318 related articles for article (PubMed ID: 23292347)
1. Antimalarial pharmacology and therapeutics of atovaquone.
Nixon GL; Moss DM; Shone AE; Lalloo DG; Fisher N; O'Neill PM; Ward SA; Biagini GA
J Antimicrob Chemother; 2013 May; 68(5):977-85. PubMed ID: 23292347
[TBL] [Abstract][Full Text] [Related]
2. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone and proguanil hydrochloride for treatment of malaria.
Kremsner PG; Looareesuwan S; Chulay JD
J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
[TBL] [Abstract][Full Text] [Related]
5. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
Boggild AK; Parise ME; Lewis LS; Kain KC
Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
[TBL] [Abstract][Full Text] [Related]
6. The conundrum of malaria chemoprophylaxis.
Shanks D
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
Nakato H; Vivancos R; Hunter PR
J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
[TBL] [Abstract][Full Text] [Related]
9. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
Schnyder JL; de Jong HK; Bache EB; van Hest RM; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
Travel Med Infect Dis; 2023; 52():102520. PubMed ID: 36526126
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
Meltzer E; Schwartz E
J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30535377
[No Abstract] [Full Text] [Related]
11. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
McKeage K; Scott L
Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of atovaquone and proguanil hydrochloride.
Beerahee M
J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
[TBL] [Abstract][Full Text] [Related]
13. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
[TBL] [Abstract][Full Text] [Related]
14. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
15. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria.
Kain KC
BioDrugs; 2003; 17 Suppl 1():23-8. PubMed ID: 12785875
[TBL] [Abstract][Full Text] [Related]
16. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
17. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
[TBL] [Abstract][Full Text] [Related]
18. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
[TBL] [Abstract][Full Text] [Related]
19. Recognition and Management of Malaria.
Gerstenlauer C
Nurs Clin North Am; 2019 Jun; 54(2):245-260. PubMed ID: 31027664
[TBL] [Abstract][Full Text] [Related]
20. [Value of malarone in therapy of malaria tropica].
Ziegler T; Schau A; Winkler C
Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
